Back to Authors

Engelstad, JaNean

0009-0004-2402-3423

Mayo Clinic

Mayo Clinic

Citations 38

A Rare Case of Peripheral Neurolymphomatosis in Cutaneous T-cell Lymphoma (P1.9-040)
Engelstad, JaNean , Spinner, Robert J. , Pupillo, Gregory, Dyck, P. James B. , Paul, Pritikanta

Neurology | December 7, 2023 | Volume: 92 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.92.15_supplement.p1.9-040 Get It

Polyneuropathy from Wild Transthyretin Amyloidosis: An Important New Variety (P3.156)
Dyck, P. James B. , Grogan, Martha , Litchy, William J. , Engelstad, JaNean , Davies, Jenny , Klein, Christopher J.

Neurology | December 7, 2023 | Volume: 86 | Issue: 16_supplement | Pages: No page available

10.1212/wnl.86.16_supplement.p3.156 Get It

Nerve Biopsy Supports Ischemic Axonal Neuropathy in Meralgia Paresthetica (P02.178)
Berini, Sarah E. , Spinner, Robert J. , Jentoft, Mark E. , Engelstad, JaNean , Suanprasert, Narupat , Dyck, P. James B. , Staff, Nathan P. , Klein, Christopher J.

Neurology | December 7, 2023 | Volume: 80 | Issue: 7_supplement | Pages: No page available

10.1212/wnl.80.7_supplement.p02.178 Get It

Nerve pathologic features differentiate POEMS syndrome from CIDP (S42.004)
Piccione, Ezequiel, Engelstad, JaNean , Dyck, P. James B. , Mauermann, Michelle L. , Dispenzieri, Angela

Neurology | December 6, 2023 | Volume: 84 | Issue: 14_supplement | Pages: No page available

10.1212/wnl.84.14_supplement.s42.004 Get It

A Unique Presentation of Amyloid-like IgM Deposition Neuropathy with Microvasculitis. (P9-13.007)
Soontrapa, Pannathat , Dyck, P. James B. , Berini, Sarah E. , Engelstad, JaNean , Shouman, Kamal , Klein, Christopher J. , Chompoopong, Pitcha

Neurology | December 6, 2023 | Volume: 98 | Issue: 18_supplement | Pages: No page available

10.1212/wnl.98.18_supplement.2284 Get It

Sural Nerve Biopsy Assessment by Individual Histologic Preparations: An Observational Cohort Study of 100 Consecutive Cases (P11-8.001)
Soontrapa, Pannathat , Dyck, P. James B. , Engelstad, JaNean , Davies, Jenny , Harmsen, William S. , Mandrekar, Jayawant N. , Spinner, Robert J. , Shelly, Shahar , Ida, Cristiane M. , Klein, Christopher J.

Neurology | April 28, 2023 | Volume: 100 | Issue: 17_supplement_2 | Pages: No page available

10.1212/wnl.0000000000201860 Get It

Sural nerve biopsy utility by masked assessment of individual histologic preparations
Soontrapa, Pannathat , Dyck, P. James B. , Klein, Caroline M., Engelstad, JaNean , Davies, Jenny , Harmsen, William S. , Mandrekar, Jay , Spinner, Robert J. , Shahar, Shelly, Klein, Christopher J , Shelly, Shahar , Ida, Cristiane M. , Klein, Christopher J.

Journal of the Peripheral Nervous System | April 5, 2023 | Volume: 28 | Issue: 2 | Pages: 191-201

10.1111/jns.12545 Get It

AbstractBackground and AimsComprehensive study of sural nerve biopsy utility based on individual histopathologic preparations is lacking. We aimed to quantify the value of different histologic preparations in diagnosis.MethodsOne hundred consecutive sural nerves were studied by standard histological preparations plus graded teased nerve fibers (GTNF), immunohistochemistry, and epoxy‐semithin morphometry. Three examiners scored the individual preparations separately by a questionnaire of neuropathic and interstitial abnormalities, masked to the biopsy number, versus a gold‐standard of all preparations. Multivariate modeling was utilized to determine best approach versus the gold‐standard.ResultsHighest confidence (range 8–9 of 10) and inter‐rater reliability (99%) for fiber abnormalities came from GTNF, and interstitial abnormalities from paraffin stains (range 7–8, 99%). Vasculitic neuropathy associated with GTNF axonal degeneration (moderate to severe 79%) with OR 3.8, 95% CI (1.001–14.7), p = .04, but not significantly with the other preparations. Clinicopathologic diagnoses associated with teased fiber abnormalities in chronic inflammatory demyelinating polyradiculoneuropathy, 80% (8/10); amyloidosis, 50% (1/2); adult‐onset polyglucosan disease 100% (1/1). GTNF and paraffin stains significantly correlated with fiber density determined by morphometric analysis (GTNF: OR 9.9, p < .0001, paraffin: OR 3.8, p = .03). GTNF combined with paraffin sections had highest accuracy for clinicopathologic diagnoses and fiber density with 0.86 C‐stat prediction versus morphometric analysis. Pathological results lead to initiation or changes of immunotherapy in 70% (35/50; initiation n = 22, reduction n = 9, escalation n = 4) with the remaining having alternative intervention or no change.InterpretationNerve biopsy paraffin stains combined with GTNF have highest diagnostic utility, confidence, inter‐rater reliability, improving accuracy for a pathologic diagnosis aiding treatment recommendations. Immunostains and epoxy preparations are also demonstrated useful supporting consensus guidelines. This study provides class II evidence for individual nerve preparation utility.
Nitrofurantoin and Minocycline–Associated Vasculitic Neuropathy: Case Reports and Literature Review
Aladawi, Mohammad , Shelly, Shahar, Dyck, P. James B. , Engelstad, JaNean , Piccione, Ezequiel, Koster, Matthew, Shelly, Shahar , Koster, Matthew J. , Naddaf, Elie

Journal of Clinical Neuromuscular Disease | November 21, 2022 | Volume: 24 | Issue: 2 | Pages: 85-94

10.1097/cnd.0000000000000404 Get It

Abstract Background: Vasculitic neuropathies usually present acutely to subacutely, with an asymmetric pattern, involving multiple peripheral nerve territories. Drug-induced vasculitis is an often overlooked etiology of vasculitic neuropathy. Methods: We present the first reported case of nitrofurantoin-associated and an illustrative case of minocycline-associated vasculitic neuropathy, with a review of the literature. Results: The first patient is a 60-year-old woman who developed axonal sensorimotor peripheral neuropathy after nitrofurantoin use, with a superficial radial nerve biopsy confirming vasculitis. The second patient is a 23-year-old woman, with a history of acne vulgaris treated with minocycline, who presented with a subacute right common peroneal mononeuropathy followed by a left deep peroneal mononeuropathy, with elevated antinuclear, perinuclear-antineutrophil cytoplasmic, and myleoperoxidase antibodies, and MPO titers, and a sural nerve biopsy showing large arteriole vasculitis. Finally, we provide a comprehensive review of previously published cases. Conclusions: Medications should be considered as a trigger for medication-induced vasculitic neuropathy. Accurate diagnosis would ensure timely treatment.